Valiant Laboratories Ltd Half Yearly Results

Gross Sales

40.36

71.1

110.95

162.04

171.87

Excise Duty

0

0

0

0

0

Net Sales

40.36

71.1

110.95

162.04

171.87

Other Operating Income

0

0

0

0

0

Other Income

6.17

4.28

5.4

3.52

1.34

Total Income

46.53

75.38

116.36

165.56

173.21

Total Expenditure

49.49

81.94

108.53

142.18

156.63

PBIDT

-2.96

-6.56

7.83

23.38

16.58

Interest

0.06

0.04

0.04

0.07

0.19

PBDT

-3.02

-6.6

7.79

23.31

16.39

Depreciation

1.05

1.01

0.95

0.84

0.72

Minority Interest Before NP

0

0

0

0

0

Tax

0.26

-2.91

1.93

4.73

4.07

Deferred Tax

0.92

0.04

-0.15

0.09

0.25

Reported Profit After Tax

-5.25

-4.74

5.06

17.65

11.35

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-5.25

-4.74

5.06

17.65

11.35

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

-5.25

-4.74

5.06

17.65

11.35

EPS (Unit Curr.)

-0.33

0

1.55

5.42

6.97

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

43.45

43.45

32.56

32.56

16.28

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-7.33

-9.22

7.05

14.42

9.64

PBDTM(%)

-

-

-

-

-

PATM(%)

-13

-6.66

4.56

10.89

6.6